BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1558197)

  • 1. Role of intracellular thiols in release of EDRF from cultured endothelial cells.
    Hecker M; Siegle I; Macarthur H; Sessa WC; Vane JR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H888-96. PubMed ID: 1558197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfhydryl-depleting agents, but not deferoxamine, modulate EDRF action in cultured pulmonary arterial cells.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1993 Sep; 265(3 Pt 1):L220-7. PubMed ID: 8214082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of thiol-modulating agents on endothelial NO bioactivity.
    Huang A; Xiao H; Samii JM; Vita JA; Keaney JF
    Am J Physiol Cell Physiol; 2001 Aug; 281(2):C719-25. PubMed ID: 11443071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of prostacyclin and EDRF from endothelial cells is differentially controlled by extra- and intracellular calcium.
    Lückhoff A
    Eicosanoids; 1988; 1(1):5-11. PubMed ID: 3152425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F
    Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
    Lückhoff A; Pohl U; Mülsch A; Busse R
    Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells.
    Graier WF; Myers PR; Rubin LJ; Adams HR; Parker JL
    Circ Res; 1994 Oct; 75(4):659-68. PubMed ID: 7923612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.
    Förstermann U; Pollock JS; Schmidt HH; Heller M; Murad F
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1788-92. PubMed ID: 1705708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
    Parsaee H; McEwan JR; Joseph S; MacDermot J
    Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.